Depressed Men with PCa are Less Likely to Undergo Definitive Therapy and Experience Worse OS

August 1, 2014

Effect of Depression on Diagnosis, Treatment, and Mortality of Men with Clinically Localized Prostate Cancer

Sandip M. Prasad, MD, MPhil
Medical University of South Carolina


Click HERE to read the abstract

Click HERE to watch a video blog from the editor-in-chief, Tom Keane, MD


Dr. Prasad received his undergraduate degree with highest honors from Harvard University, a Master’s degree in Epidemiology from the University of Cambridge, and his medical degree from the Duke University School of Medicine (where he graduated Alpha Omega Alpha). He completed his urology training at the Harvard Program in Urology and a two-year Society of Urologic Oncology minimally-invasive urologic oncology fellowship at the University of Chicago prior to joining the Medical University of South Carolina, where he is an assistant professor and urology residency program director.

He has served as the principal investigator or coinvestigator on multiple clinical trials funded by the National Institutes of Health as well as industry. He is primarily interested in optimizing health outcomes for patients with urologic disease through judicious use of screening and treatment. His research has been published over 50 times in such peer-reviewed journals as the Journal of the American Medical Association, the Journal of Clinical Oncology, Cancer, the Journal of Urology, Urology, and Urologic Oncology. His teaching and clinical interests have been recognized with several awards from the American Urological Association, the Bladder Cancer Advocacy Network, and the American Society of Clinical Oncology.